General Session IV (105) Featured

7–7:50 am Sunday, April 29

View a recording of this live session when you purchase 2018 Annual Meeting On Demand.

The final AAPM 34th Annual Meeting plenary sessions will focus on the late-breaking findings of consensus guidelines about the use of ketamine for acute and chronic pain.

Guidelines for the Use of Ketamine to Treat Acute and Chronic Pain

An expert panel will offer insight into key findings on indications for the use of ketamine, optimal dosing, physiological monitoring, and contraindications from a newly developed clinical guideline.

Ketamine: Development of the ASRA, AAPM, and ASA Guidelines for Chronic Pain Recommendations for Use

Stephen P. Cohen, MD

Pre-Treatment Testing and Monitoring for Ketamine Infusions

Robert W. Hurley, MD PhD

Contraindications for Ketamine Infusions

Ajay D. Wasan, MD MSc

Clinical Indications and Treatment Effects of Ketamine for Chronic Pain

W. Michael Hooten, MD

Learning Objectives:

  • Identify patient subgroups where ketamine use is indicated.
  • Select optimal dose and duration of ketamine administration for acute and chronic pain.
  • Demonstrate working knowledge about which physiological monitors are needed to safely administer ketamine.